Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REYATAZ vs RIBOCICLIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REYATAZ vs RIBOCICLIB: Safety Overview

Metric REYATAZ RIBOCICLIB
Total FAERS Reports 142 27,997
Deaths Reported 12 4,501
Death Rate 8.5% 16.1%
Hospitalizations 50 6,700
Average Patient Age 44.8 yrs 60.2 yrs
% Female Patients N/A 99.0%
FDA Approval Date N/A Mar 13, 2017
Manufacturer N/A Novartis Pharmaceuticals Corporation
Route N/A ORAL
Marketing Status N/A Prescription